Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol Poisoning
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
aim to investigate the relationship between the RDW and 7-day mortality during acute methanol poisoning.
Condition or disease
RDW values have been found to be an independent predictor of the prognosis among patients with heart diseases, stroke,community-acquired pneumonia (CAP), pulmonary embolism, chronic obstructive pulmonary disease (COPD), septic shock, and acute pancreatitis.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 88 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with acute methanol toxicity who were diagnosed and treated at the Adana City Training and Research Hospital, Mersin City Training and Research Hospital.
All patients aged ≥16 years who were admitted to both emergency departments from January 2018 to September 2019 on account of acute methanol intoxication.
prehospital cardiac arrest transfer to another hospital